Wai Chun Bio-Technology (660) Publishes 2024/2025 Annual Report

Bulletin Express
2025/10/30

Wai Chun Bio-Technology Limited (660) released its 2024/2025 Annual Report on 31 October 2025. According to the company, the digital version of this report is accessible on both its official website (www.0660.hk) and on the website of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk).

Non-registered shareholders can request a printed copy of the annual report or other corporate communications by sending a written request to the company’s Hong Kong Branch Share Registrar. They may also email the registrar for assistance. If shareholders encounter any difficulty accessing the digital version of the company’s updates, the company will provide printed copies free of charge upon request.

Shareholders holding shares through intermediaries who wish to receive corporate communications in electronic form are advised to provide a valid email address through their banks, brokers, custodians, nominees, or HKSCC Nominees Limited. For further inquiries, the Hong Kong Branch Share Registrar can be contacted during business hours.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10